Search research articles
Contact Us
Filters
Showing results (331-340 of 1,212) with videos related to
Page
of 122
Sort By:
Caries Research
|
January 1, 1979
Effect of a mineralizing solution on sections of fluorosed human dental enamel in vitro
J L Christensen, M J Larsen, O Fejerskov
Ugeskrift for Laeger
|
October 13, 2005
[Central fat deposits contribute to atherosclerosis and insulin resistance and peripheral fat deposits protect against atherosclerosis and insulin resistance in postmenopausal women--secondary publication]
Laszlo B Tanko, Bjørn Richelsen, Philip J Larsen
The Journal of Reproductive Medicine
|
March 1, 1987
Successful pregnancy after pharmacologic suppression of a circulating anticoagulant in a woman with previous pregnancy losses and pulmonary emboli. A case report
N Isada, C Kessler, J Larsen, et al.
Biology of Reproduction
|
August 1, 1994
Sequential effects of follicle-stimulating hormone and luteinizing hormone on mouse cumulus expansion in vitro
L Chen, P T Russell, W J Larsen
British Medical Journal (Clinical Research Ed.)
|
November 30, 1985
Diabetes mellitus and early mortality from stroke
T Storm, P Hildebrandt, R Sykulski, et al.
Die Medizinische Welt
|
June 4, 1976
[Dissecting aneurysm with acute aortic isthmus stenosis followed by massive intracerebral hemorrhage]
W Kirschmeyer, J Larsen, A Gröschl, et al.
Brain Research Bulletin
|
January 1, 1997
Direct link from the suprachiasmatic nucleus to hypothalamic neurons projecting to the spinal cord: a combined tracing study using cholera toxin subunit B and Phaseolus vulgaris-leucoagglutinin
N Vrang, J D Mikkelsen, P J Larsen
Biochimica Et Biophysica Acta
|
May 12, 2000
Antisense properties of peptide nucleic acid
H J Larsen, T Bentin, P E Nielsen
Neuroendocrinology
|
May 8, 2001
Leptin receptor immunoreactivity is present in ascending serotonergic and catecholaminergic neurons of the rat
A Hay-Schmidt, L Helboe, P J Larsen
Diabetes Care
|
July 27, 2001
Glucagon-like peptide-1 infusion must be maintained for 24 h/day to obtain acceptable glycemia in type 2 diabetic patients who are poorly controlled on sulphonylurea treatment
J Larsen, B Hylleberg, K Ng, et al.
Page
of 122
Search research articles
Search
Showing results (331-340 of 1,212) with videos related to
Sort By:
Page
of 122
Caries Research
|
January 1, 1979
Effect of a mineralizing solution on sections of fluorosed human dental enamel in vitro
J L Christensen, M J Larsen, O Fejerskov
Ugeskrift for Laeger
|
October 13, 2005
[Central fat deposits contribute to atherosclerosis and insulin resistance and peripheral fat deposits protect against atherosclerosis and insulin resistance in postmenopausal women--secondary publication]
Laszlo B Tanko, Bjørn Richelsen, Philip J Larsen
The Journal of Reproductive Medicine
|
March 1, 1987
Successful pregnancy after pharmacologic suppression of a circulating anticoagulant in a woman with previous pregnancy losses and pulmonary emboli. A case report
N Isada, C Kessler, J Larsen, et al.
Biology of Reproduction
|
August 1, 1994
Sequential effects of follicle-stimulating hormone and luteinizing hormone on mouse cumulus expansion in vitro
L Chen, P T Russell, W J Larsen
British Medical Journal (Clinical Research Ed.)
|
November 30, 1985
Diabetes mellitus and early mortality from stroke
T Storm, P Hildebrandt, R Sykulski, et al.
Die Medizinische Welt
|
June 4, 1976
[Dissecting aneurysm with acute aortic isthmus stenosis followed by massive intracerebral hemorrhage]
W Kirschmeyer, J Larsen, A Gröschl, et al.
Brain Research Bulletin
|
January 1, 1997
Direct link from the suprachiasmatic nucleus to hypothalamic neurons projecting to the spinal cord: a combined tracing study using cholera toxin subunit B and Phaseolus vulgaris-leucoagglutinin
N Vrang, J D Mikkelsen, P J Larsen
Biochimica Et Biophysica Acta
|
May 12, 2000
Antisense properties of peptide nucleic acid
H J Larsen, T Bentin, P E Nielsen
Neuroendocrinology
|
May 8, 2001
Leptin receptor immunoreactivity is present in ascending serotonergic and catecholaminergic neurons of the rat
A Hay-Schmidt, L Helboe, P J Larsen
Diabetes Care
|
July 27, 2001
Glucagon-like peptide-1 infusion must be maintained for 24 h/day to obtain acceptable glycemia in type 2 diabetic patients who are poorly controlled on sulphonylurea treatment
J Larsen, B Hylleberg, K Ng, et al.
Page
of 122